Polarcus Limited
Polarcus Limited (in provisional liquidation) ("Polarcus" or the "Company") (OSE: PLCS) refers to the suspension of trading in the Polarcus share announced on 9 March 2021 and to the order ("Order") of the Grand Court of the Cayman Islands ("Court") appointing named individuals as Joint Provisional Liquidators ("JPLs") of the Company (see: announcement dated 9 February 2021, Polarcus: Appointment of Joint Provisional Liquidators).
The Order requires the JPLs to submit a report to the Court by no later than 31 March 2021. The JPLs have informed the directors of the Company that they intend to submit their report within the time limit reference in the Order and the JPLs agree with the Company’s assessment that it is appropriate to maintain the suspension of trading in the Polarcus share.
The Company will issue a further announcement once the report is filed with the Court and as otherwise required in accordance with the Company’s continuing obligations.
Contacts
Hans-Peter Burlid, CFO
+971 50 559 8175
hp.burlid@polarcus.com
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S18.10.2025 12:00:34 CEST | Press release
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
F. Hoffmann-La Roche Ltd18.10.2025 07:00:00 CEST | Press release
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
StoneX Group Inc.18.10.2025 01:12:36 CEST | Press release
StoneX Expands Wealth Management Offering for Latin American Clients
F. Hoffmann-La Roche Ltd17.10.2025 22:20:00 CEST | Press release
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Eavor Technologies Inc.17.10.2025 18:00:00 CEST | Press release
Mark Fitzgerald Appointed President and Chief Executive Officer of Eavor Technologies Inc.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom